Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Abdominal pain is common in the general population and, in patients with irritable bowel syndrome, is attributed to visceral hypersensitivity. We found that oral administration of specific Lactobacillus strains induced the expression of mu-opioid and cannabinoid receptors in intestinal epithelial cells, and mediated analgesic functions in the gut-similar to the effects of morphine. These results suggest that the microbiology of the intestinal tract influences our visceral perception, and suggest new approaches for the treatment of abdominal pain and irritable bowel syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A few putative mechanisms include: microbial induction of epithelial μ-opioid and cannabinoid receptors as shown with oral administration of Lactobacillus strains in rodents69”
From The gut Microbiome in adult and pediatric functional gastrointestinal disorders (2019) · cites this paper as [69]
In the citing paper
“The use of probiotics, particularly in animal models, also demonstrates that their secreted products or metabolites can modulate contractility of intestinal smooth muscle and visceral sensitivity.59–61”
From Intestinal microbiota in functional bowel disorders: a Rome foundation report (2013) · cites this paper as [60]
In the citing paper
“Interestingly, we saw beneficial effects especially on distension and pain, as this agrees well with the recent findings that certain lactobacilli can induce the expression of pain-sensing receptors in intestinal epithelial cells. 33”
From Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota (2008) · cites this paper as [33]
In the citing paper
“In addition, exposure of rats to L. reuteri (83) or L. acidophilus NCFM (151) reduce their pain response to balloon distension, through targeting ion channels in the enteric nervous system (83, 91) or increasing the expression of μ-opioid and cannabinoid receptors in intestinal epithelial cells (151).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [151]
In the citing paper
“Evidence for such mutual interaction has been demonstrated in gut inflammation,14 visceral pain,77 certain symptoms of IBS,12 and in obesity.78”
From Principles and clinical implications of the brain-gut-enteric microbiota axis (2009) · cites this paper as [77]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Gut flora in health and disease
Guarner, F., & Malagelada, J.-R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12489-0 · Cited by 3,365
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
Falk, P. G., Hooper, L. V., Midtvedt, T., & Gordon, J. I. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.4.1157-1170.1998 · Cited by 657
Attacking pain at its source: new perspectives on opioids
Stein, C., Schäfer, M., & Machelska, H. (2003) · Nature Medicine · doi:10.1038/nm908 · Cited by 608
Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM
Altermann, E., Russell, W. M., Azcarate-Peril, M. A., Barrangou, R., Buck, B. L., McAuliffe, O., Souther, N., Dobson, A., Duong, T., Callanan, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409188102 · Cited by 590
Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice
Verdú, E. F., Bercik, P., Verma-Gandhu, M., Huang, X.-X., Blennerhassett, P., Jackson, W., Mao, Y., Wang, L., Rochat, F., & Collins, S. M. (2006) · Gut · doi:10.1136/gut.2005.066100 · Cited by 448
Cervero, F., & Laird, J. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01306-9 · Cited by 434
Invited Review: The Scientific Basis of Lactobacillus acidophilus NCFM Functionality as a Probiotic
Sanders, M. E., & Klaenhammer, T. R. (2001) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(01)74481-5 · Cited by 433
KAJANDER, K., HATAKKA, K., POUSSA, T., FÄRKKILÄ, M., & KORPELA, R. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02579.x · Cited by 361
WRIGHT, K., ROONEY, N., FEENEY, M., TATE, J., ROBERTSON, D., WELHAM, M., & WARD, S. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.026 · Cited by 299
Cited by
Items 501–600 of 793
Dairy Probiotic Foods and Bacterial Vaginosis: A Review on Mechanism of Action
Bastani, P., Homayouni, A., Gasemnezhad, V., & Ziyadi, S. (2012) · InTech eBooks · doi:10.5772/50083 · Cited by 13
“control the transmission of nociceptive information to the GI nervous system [36].”
BackgroundSyndrome de l'intestin irritable: options thérapeutiques actuelles
Ducrotte, P. R. (2007) · La Presse Médicale · doi:10.1016/j.lpm.2007.03.008 · Cited by 14
Psychobiotics; A Promise for Neurodevelopmental Therapy
Daliri, E. B., & Oh, D. (2016) · Journal of Probiotics & Health · doi:10.4172/2329-8901.1000146 · Cited by 17
“Chronic administration of Bifidobacteria infantis to rats has shown to increase plasma tryptophan levels relative to control groups and the increased tryptophan levels affect central neurochemical functions [49].”
BackgroundCoccurello, R., Marrone, M. C., & Maccarrone, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.869606 · Cited by 14
“acidophilus-mediated analgesic effects were inhibited by CB2 receptors blockade (Rousseaux et al., 2007).”
BackgroundInfluentialRole of the Endocannabinoidome in Human and Mouse Atherosclerosis
Piscitelli, F., & Silvestri, C. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190826162735 · Cited by 13
The gut microbiota and disease – an inner repository for drug discovery
Shanahan, F., & Kiely, B. (2007) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.02.006 · Cited by 12
Kashyap, Y., & Wang, Z. J. (2023) · Pain · doi:10.1097/j.pain.0000000000003034 · Cited by 11
Barker, H., & Ferraro, M. J. (2024) · Infection and Immunity · doi:10.1128/iai.00020-24 · Cited by 11
“Administration of this probiotic strain leads to a notable upregulation of CB 2 R transcript expression in mice (161), indicating that specific microbial strains could beneficially influence CB 2 R expression and thus contribute to gut health regulation.”
BackgroundCampanale, A., Siniscalco, D., & Marzo, V. D. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01145-7 · Cited by 16
“Some GM strains have been reported to influence the eCB system and exert anti-inflammatory effects [45].”
Using integrated meta-omics to appreciate the role of the gut microbiota in epilepsy
Boeri, L., Donnaloja, F., Campanile, M., Sardelli, L., Tunesi, M., Fusco, F., Giordano, C., & Albani, D. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105614 · Cited by 11
“epithelial cells (Rousseaux et al., 2007), and LPS modulates endocannabinoid receptors agonist synthesis in immune cells (Liu et al.”
Maillard, F., Meynier, M., Mondot, S., Pepke, F., Galbert, C., Torres-Maravilla, E., Kropp, C., Sokol, H., Carvalho, F. A., Jacouton, E., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11040906 · Cited by 12
“For example, Liquoralilactobacillus salivarius Ls33 displays anti-inflammatory properties [17], Lactobacillus acidophilus NCFM mediates analgesic functions [18] and Lacticaseibacillus rhamnosus LGG has beneficial effects on the intestinal barrier [19], but the effects are highly strain specific.”
Therapeutic potential of CBD in Autism Spectrum Disorder
Pedrazzi, J. F. C., Hassib, L., Ferreira, F. R., Hallak, J. E. C., Del-Bel, E., & Crippa, J. A. S. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.05.002 · Cited by 14
Rosas, R. F., Emer, A. A., Batisti, A. P., Lüdtke, D. D., Turnes, B. L., Bobinski, F., Cidral‐Filho, F. J., & Martins, D. F. (2018) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2018.08.002 · Cited by 11
Lactic Acid Bacteria: Lactobacillus spp.: Lactobacillus acidophilus
Özoğul, F., & Hamed, I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-100596-5.00852-0 · Cited by 13
Probiotics and Health Claims: Challenges for Tailoring their Efficacy
Chassard, C., Grattepanche, F., & Lacroix, C. (2010) · Wiley eBooks · doi:10.1002/9781444329384.ch4 · Cited by 16
From bugs to behavior: targeting the gut-brain interface for addiction therapeutics
Ru, Y., Jia, J., Yang, X., Ba, X., Yan, J., Zhang, H., & Zhang, Y. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2569740 · Cited by 10
“172 Crawford et al. found that the ketogenic diet alleviate abnormal pain behaviors induced by chronic morphine treatment in male mice by restoring SCFA-producing bacteria.”
Zhong, F., Xu, M., Schelli, K., Rutowski, J., Holmén, B. A., & Zhu, J. (2017) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2017.04.002 · Cited by 10
Li, Y., Yu, Y., Wu, X., Liu, B., Ma, H., Zhao, X., Cao, S., Ding, S., Li, T., Wang, X., et al. (2022) · Nutrition · doi:10.1016/j.nut.2022.111802 · Cited by 17
Peng, S., Xia, Y., Wang, Y., Yu, X., Wu, Z., Zhang, L., Xu, K., Shen, L., & Luo, H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1220418 · Cited by 11
“Conversely, the application of certain Lactobacillus strains augmented the expression of cannabinoid receptors in the intestinal epithelial cells, conveying analgesic functions within the digestive tract in a mouse model (Rousseaux et al., 2007).”
BackgroundThe emerging role of Lactobacillus acidophilus in the cervicovaginal microenvironment
Molina, M. A., Melchers, W. J. G., Núñez-Samudio, V., & Landires, I. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00315-4 · Cited by 10
Mărginean, C. M., Popescu, M., Drocaș, A. I., Cazacu, S. M., Mitruţ, R., Mărginean, I. C., Iacob, G. A., Popescu, M. S., Docea, A. O., & Mitruț, P. (2023) · Gastrointestinal Disorders · doi:10.3390/gidisord5040043 · Cited by 11
Probiotics and fermented dairy foods - a review
Wendling, L. K., & Weschenfelder, S. (2013) · Revista do Instituto de Latícinios Cândido Tostes · doi:10.5935/2238-6416.20130048 · Cited by 10
Commercial Strains of Lactic Acid Bacteria with Health Benefits
Tang, X., & Zhao, J. (2019) · Springer eBooks · doi:10.1007/978-981-13-7832-4_10 · Cited by 10
Mischel, R. A., Muchhala, K. H., Dewey, W. L., & Akbarali, H. I. (2019) · Journal of Pain · doi:10.1016/j.jpain.2019.11.015 · Cited by 11
Microbiome contributions to pain: a review of the preclinical literature
Pratt, M. L., Plumb, A. N., Manjrekar, A., Cardona, L. M., Chan, C. K., John, J. M., & Sadler, K. E. (2024) · Pain · doi:10.1097/j.pain.0000000000003376 · Cited by 9
Tan, W.-W., Liu, Z.-X., Liu, X.-Y., Zhang, W., Zheng, L., Zhang, Y.-L., & Dai, Y.-C. (2024) · Pain and Therapy · doi:10.1007/s40122-024-00672-9 · Cited by 14
Symphony of the gut microbiota and endocannabinoidome: a molecular and functional perspective
Wang, Y., Guo, J., Mao, Z., & Chen, Y. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1566290 · Cited by 13
Xie, Y., Lv, G., Su, D., Li, M., Xu, Q., Chen, H., Cheng, F., & Dai, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1647466 · Cited by 9
“Furthermore, previous studies have established that endocannabinoid signaling enhances gut barrier integrity and synergizes with microbial metabolites like butyrate to exert systemic anti-in fl ammatory effects (40, 41).”
Kolli, U., & Roy, S. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1233194 · Cited by 11
“with probiotic Lactobacillus acidophilus was shown to attenuate abdominal pain by mediating the expression of OPRM1 and cannabinoid receptors (CB2) in the intestinal epithelial cells in an Nf-kb-dependent mechanism (Rousseaux et al., 2007),”
BackgroundGut bacteria, endocannabinoid system, and marijuana addiction: Novel therapeutic implications
Pinapati, K. K., Vidya, S., Khan, M. F., Mandal, D., & Banerjee, S. (2023) · Health Sciences Review · doi:10.1016/j.hsr.2023.100144 · Cited by 9
Wiącek, J., Podgórski, T., Kusy, K., Łoniewski, I., Skonieczna‐Żydecka, K., & Karolkiewicz, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115611 · Cited by 10
“…acidophilus in mice could upregulate the intestinal expression of cannabinoid receptors, significantly mitigating visceral pain through a mechanism mediated by CB2 and opioid receptors, thereby underscoring the endocannabinoid system’s (ECS) pivotal role in managing intestinal health [17].”
BackgroundMethodPsychobiotics: can gut microbiota infl uence host’s mental health?
Kirpichenka, A. A., & Kim, I. Y. (2017) · Vestnik of Vitebsk State Medical University · doi:10.22263/2312-4156.2017.2.26 · Cited by 12
“Эти данные сопоставимы с сообщением об устойчивости к экспериментальной депрессии, развивающейся у мышей с гиперэкспрессией CB2-рецепторов [64].”
Polysaccharides, Next Potential Agent for the Treatment of Epilepsy?
Xie, X., Wu, Y., Xie, H., Wang, H., Zhang, X., Yu, J., Zhu, S., Zhao, J., Sui, L., & Li, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.790136 · Cited by 10
“, 2019), as well as the endocannabinoid system (Rousseaux et al., 2007) and brain-derived neurotrophic factor level, may be affected by gut microbiota, and therefore further effect on the seizure mechanism.”
BackgroundLima, P. A., Berg, B. B., & Castor, M. G. M. E. (2022) · Intestinal Research · doi:10.5217/ir.2021.00160 · Cited by 12
“It was demonstrated that the probiotic agent Lactobacillus acidophilus promoted an increase in the expression of CB2R in the epithelium of rats and mice and a consequent reduction in visceral sensitivity in cases of irritation and inflammation.(64) A possible mechanism for pain regulation from CB2R would be the inhibi…”
BackgroundHigh and Mighty? Cannabinoids and the microbiome in pain
Rea, K., O’Mahony, S. M., & Cryan, J. F. (2021) · Neurobiology of Pain · doi:10.1016/j.ynpai.2021.100061 · Cited by 12
Commercially Available Human Probiotic Microorganisms
Hoppe, C., Larsen, C. N., Fondén, R., Svensson, U., Ouwehand, A. C., Lahtinen, S. J., Kiwaki, M., Nomoto, K., Kimura, K., Eskesen, D. C., et al. (2008) · Wiley eBooks · doi:10.1002/9780470432624.ch6 · Cited by 13
Self-citationLactic Acid Bacteria | Lactobacillus spp.: Lactobacillus acidophilus
Gopal, P. K. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-374407-4.00260-0 · Cited by 9
Shao, H., Wang, L., & Zhang, H. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1502373 · Cited by 8
“…on the effect of inducing the expression of µ-opioid and cannabinoid receptors in intestinal epithelial cells and mediating analgesic functions in the gut, L. acidophilus was recognized as a potential therapeutic approach for abdominal pain and irritable bowel syndrome (Rousseaux et al., 2007).”
Luo, J., Xu, Q., Xu, S., Zhai, L., Yuan, C., & Bian, Z. (2025) · Current Gastroenterology Reports · doi:10.1007/s11894-025-00967-7 · Cited by 9
“Some species in the Lactobacillus genus, for instance, L. paracasei [49], L. acidophilus [50], L. rhamnosus and L. plantarum [51, 52], have been shown to ameliorate abdominal pain in the antibiotics-induced VH mouse model.”
Ivashkevich, D., Ponomarenko, A. I., Manzhulo, I., Sultanov, R. M., & Dyuizen, I. V. (2023) · Nutrients · doi:10.3390/nu15204345 · Cited by 8
“It is known that the microbiota can modulate endocannabinoid activity in the gut [67,68]; moreover, the expression of endogenous OEA-DS in the gut may also depend on the composition of the microbiota [69].”
BackgroundShen, C., Santos, J. M., Elmassry, M. M., Bhakta, V., Driver, Z., Ji, G., Yakhnitsa, V., Kiritoshi, T., Lovett, J., Hamood, A. N., et al. (2024) · Antioxidants · doi:10.3390/antiox13050502 · Cited by 11
“Gut dysbiosis has been implicated in the onset or progression of NP-associated behavior, such as pain sensitivity [5–8].”
BackgroundDiverticular disease: diagnosis and treatment
Špičák, J., Kučera, M., & Suchánková, G. (2018) · Vnitřní lékařství · doi:10.36290/vnl.2018.086 · Cited by 8
“Bolest a její vnímání ovlivňují ně které kmeny laktobacilů indukcí exprese mikroopioid ních a kanabioidních receptorů ve střevní sliznici [101].”
Sex‐dependent impact of microbiota status on cerebral μ‐opioid receptor density in fischer rats
Effah, F., Silva, N. K. D. G. T., Vijayanathan, K., Camarini, R., Joly, F., Taiwo, B., Rabot, S., Champeil‐Potokar, G., Bombail, V., & Bailey, A. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15666 · Cited by 8
Han, S., Gao, J., Wang, Z., Xiao, Y., Ge, Y., Liang, Y., & Gao, J. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1343763 · Cited by 8
Chitin-glucan improves important pathophysiological features of irritable bowel syndrome
Valibouze, C., Dubuquoy, C., Chavatte, P., Génin, M., Maquet, V., Modica, S., Desreumaux, P., & Rousseaux, C. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i16.2258 · Cited by 8
“Since these receptors are highly expressed in epithelial cells[23,39], we conducted a series of in vitro experiments using human intestinal HT-29 epithelial cells showing increased expression of MOR and CB2R mRNA, starting after cell incubation with different concentrations of chitin-glucan,…”
InfluentialSelf-citationGut microbes as modulators of the neuro-immuno-endocrine system
Forsythe, P. (2013) · PharmaNutrition · doi:10.1016/j.phanu.2013.05.003 · Cited by 9
Prebiotics for irritable bowel syndrome
Quigley, E. M. M. (2009) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.09.46 · Cited by 9
Probiotics and Prebiotics in Human Health
Brunser, O., & Gotteland, M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374938-3.00006-2 · Cited by 12
Gut Microbiota and Probiotics in Perioperative Management: A Narrative Review
Kurdi, M. S., Bajwa, S. S., Sharma, R. B., & Choudhary, R. (2024) · Cureus · doi:10.7759/cureus.68404 · Cited by 12
Probiotics in the Modern World
Uspenskiy, Y. P., Fominykh, Y. A., Наджафова, К. Н., & Polyushkin, S. V. (2020) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2020-30-3-24-35 · Cited by 10
Thambi, M., Nathan, J. K., & Radhakrishnan, K. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2020.107444 · Cited by 7
Shin, J., Chung, W., Park, Y.-S., & Nam, Y. (2022) · LWT · doi:10.1016/j.lwt.2022.114166 · Cited by 8
Cannabinoids and GI Disorders: Endogenous and Exogenous
Reichenbach, Z. W., & Schey, R. (2016) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-016-0111-1 · Cited by 7
Advancements in drug development for diarrhea-predominant irritable bowel syndrome
Dothel, G., Barbaro, M. R., Raschi, E., Barbara, G., & Ponti, F. D. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1442434 · Cited by 7
Santonicola, A., Molinari, R., Piccinocchi, G., Salvetti, A., Natale, F., & Cimmino, G. (2023) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v13i2.1068 · Cited by 8
The role of gut microbiota in non-alcoholic fatty liver disease pathogenesis
Yaghmaei, H., Nojoumi, S. A., Soltanipur, M., Yarmohammadi, H., Mirhosseini, S. M., Rezaei, M., Nadoushan, M. J., & Siadat, S. D. (2024) · Obesity Medicine · doi:10.1016/j.obmed.2024.100551 · Cited by 7
Karitnig, R., Bogner, A., Jahn, N., Vlachos, C., Lederer, A. A., Geisler, A. A., Sucher, R., & Hau, H. M. (2025) · Medicina · doi:10.3390/medicina61061068 · Cited by 6
Prete, R., Merola, C., García-González, N., Fanti, F., Angelozzi, G., Sergi, M., Battista, N., Perugini, M., & Corsetti, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-70053-x · Cited by 6
“First proof of the mutual ECS-microbiota interaction was highlighted in 2007 34 and since then there is a body of evidence regarding this dynamic crosstalk, including microbial metabolites, short chain fatty acids, cannabinoid receptors, and TLRs 35–38 .”
BackgroundCapirchio, L., Rousseaux, C., Dubuquoy, C., Ouwehand, A. C., Maquet, V., Modica, S., Louis, E. J., Desreumaux, P., & Tack, J. F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910732 · Cited by 6
“This response is characterized by an elevation of the hind part of the animal’s body and clearly visible abdominal contraction corresponding to severe contractions [23,50,51].”
BackgroundMethodInfluentialSelf-citationPharmacological approaches to treat intestinal pain
Świerczyński, M., Makaro, A., Grochowska, A., & Sałaga, M. (2023) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2195626 · Cited by 9
Kazura, W., Michalczyk, K., & Stygar, D. M. (2023) · Nutrients · doi:10.3390/nu15143082 · Cited by 7
“Oral administration of Lactobacillus acidophilus in mice and rats led to an increased expression of intestinal epithelial cannabinoid receptor 2 (CB2R) [142].”
BackgroundRossi, R. E., Rossi, L., & Fassio, F. (2015) · Journal of Contemporary Immunology · doi:10.7726/jci.2015.1003 · Cited by 7
The Important Role of the Endocannabinoid System and the Endocannabinoidome in Gut Health.
Meletis, C. D. (2019) · PubMed · Cited by 6
Microbiome First Approaches in Pain Prevention and Management
Dietert, R. R. (2021) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2021.14.001976 · Cited by 6
“While a variety of microbiome studies are described within the review articles in Table 1, the most recent preclinical and clinical trials from the past 2-3 years are highlighted in Table 2 [52-71].”
BackgroundNandi, S. K., Basu, S., Bhattacharjya, A., Ghosh, R. D., Bose, C. K., Mukhopadhyay, S., & Bhattacharya, R. K. (2022) · Nutrition · doi:10.1016/j.nut.2022.111787 · Cited by 6
The emerging role of the microbial-gastrointestinal-neural axis
McLean, P. G., Calver, A. R., Alpers, D., Collins, S. M., Shanahan, F., & Lee, K. (2009) · Gastroenterology Insights · doi:10.4081/gi.2009.e3 · Cited by 6
“have been linked with a range of activities from immunomodulatory properties(32) to eliciting analgesic effects.(33) 3.”
BackgroundGut-Brain Axis: Probiotic Interactions and Implications for Human Mental Health
Gayathri, D., Vasudha, M., & Prashantkumar, C. S. (2022) · Springer eBooks · doi:10.1007/978-981-16-1626-6_11 · Cited by 6
The Human Microbiome in Health and Disease
Hill, C. J., Ross, R. P., Stanton, C., & O’Toole, P. W. (2016) · Wiley eBooks · doi:10.1002/9783527682386.ch4 · Cited by 7
Gomes, P., Laroute, V., Beaufrand, C., Daveran‐Mingot, M., Aubry, N., Liebgott, C., Ballet, N., Legrain–Raspaud, S., Théodorou, V., Mercier‐Bonin, M., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202301588r · Cited by 5
“35-39 To our knowledge, only a Bifidobacterium strain was reported to have antinociceptive properties against VH after only 5 days of treatment, as seen in our study.”
ResultEndogenous Cannabinoids in Crohn’s Disease
Bochenek, M. S., Tomasik, J. T., Wędrychowicz, A., & Tomasik, P. (2024) · Applied Sciences · doi:10.3390/app14156646 · Cited by 6
Microbiota—A Rescuing Modulator in Children Struggling with Functional Constipation
Tomsa, N., Meliţ, L. E., Popescu, T., Najjar, K., Văsieșiu, A.-M., Pop, A. V., & Balas, R. B. (2025) · Microorganisms · doi:10.3390/microorganisms13071504 · Cited by 8
“The positive impact of probiotics on the gut ecosystem of patients suffering from constipation has been explained by mechanisms like replenishing lacking beneficial resident bacteria, downregulating mucosal inflammation, or producing SCFAs [1,31,39,40].”
Selection and Evaluation of Probiotics
Pérez‐Martínez, G., Bäuerl, C., & Amores, M. (2012) · CRC Press eBooks · doi:10.1201/b11653-34 · Cited by 5
García-González, N., Colom, J., Harris, H. M. B., Strain, C., Stanton, C., Hill, C., Corsetti, A., & Gahan, C. G. M. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.832513 · Cited by 5
Why Use Nutraceutical Strategies for the Irritable Bowel Syndrome?
di Michele, F. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210917115255 · Cited by 5
Drugs and bugs: Negative affect, psychostimulant use and withdrawal, and the microbiome
Forouzan, S., McGrew, K., & Kosten, T. A. (2021) · American Journal on Addictions · doi:10.1111/ajad.13210 · Cited by 5
Probiotics in Irritable Bowel Syndrome
Meier, R. F. (2010) · Annals of Nutrition and Metabolism · doi:10.1159/000309017 · Cited by 5
“It is well known that specific bacteria strains have numerous positive effects in the gastrointestinal tract. Probiotics reduce the adherence of pathogen bacteria on the epithelial cells and thus the ability of pathogen bacterial translocations. Probiotics can control the growth of pathogen bacteria by stimulating the…”
BackgroundTolerogenic probiotics and gut-brain axis: targeting pain receptors in neuroimmune disorders
Ahmadi‐Khorram, M., Hatami, A., Forouzanfar, F., Afshari, A., & Esmaeili, S. (2025) · Nutritional Neuroscience · doi:10.1080/1028415x.2025.2567415 · Cited by 4
“Variability in probiotic strains leads to inconsistent outcomes, influenced by host microbiota and disease-specific factors [5].”
InfluentialThe Role of Probiotics in the Treatment of Irritable Bowel Syndrome
Parkes, G. C. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374938-3.00030-x · Cited by 6
Dyson, G., Barrett, M. R., Schlupp, L., Prinz, E., Hanebutt, N., Szymczak, A., Brawner, C. M., & Jeffries, M. A. (2025) · ACR Open Rheumatology · doi:10.1002/acr2.11794 · Cited by 4
“Conversely, previous studies have found that Lactobacillus modulates intestinal pain by inducing endogenous opioid and cannabinoid receptors 43 and Lactobacillus dietary supplementation reduces bone cancer-induced mechanical allodynia 44 in rats, consistent with our current fi nding of Lactobacillus…”
Schmulson (2025) · doi:10.1016/j.rgmx.2024.10.003 · Cited by 3
Remes-Troche, J. M., Coss‐Adame, E., Schmulson, M. J., García‐Zermeño, K. R., Amieva‐Balmori, M., Carmona-Sánchez, R., Gomez-Escudero, O., Gómez-Castaños, P. C., Icaza-Chávez, M. E., López‐Colombo, A., et al. (2025) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2024.10.009 · Cited by 13
Potential Molecular Mechanism of Probiotics in Alcoholic Liver Disease
Patel, D. N., Patel, F., & Mandal, P. (2017) · Journal of Alcoholism and Drug Dependence · doi:10.4172/2329-6488.1000278 · Cited by 5
“Many of the beneficial therapeutic effects of probiotics may result from (1) transition of the intestinal microbiota composition as well as production of antibacterial factor; (2) improvement of intestinal epithelial permeability and function; and/or (3) modulation of both immune system: local and systemic levels (4)…”
BackgroundPillai, N. V., Berean, K. J., Brkljača, R., Greve, L. J., Kasapis, S., & Kalantar‐Zadeh, K. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.05.054 · Cited by 4
Maixent, J. M., Pons, O., Sennoune, S. R., & Sadrin, S. (2020) · Cellular and Molecular Biology · doi:10.14715/cmb/2020.66.3.34 · Cited by 7
Mechanisms of Gut Microbiota Modulation by Food, Probiotics, Prebiotics and More
Molinero, N., Sabater, C., Calvete‐Torre, I., Delgado, S., Ruas‐Madiedo, P., Ruíz, L., & Margollés, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00095-4 · Cited by 4
Medical Therapy of Hemorrhoidal Disease
Scaldaferri, F., Ingravalle, F., Zinicola, T., Holleran, G. E., & Gasbarrini, A. (2018) · Coloproctology · doi:10.1007/978-3-319-53357-5_6 · Cited by 5
Place of probiotics in the prevention and treatment of antibiotic-associated diarrhea
Plotnikova, E. Y., & Zakharova, Y. V. (2015) · Terapevticheskii arkhiv · doi:10.17116/terarkh2015875127-131 · Cited by 4
Overview of Probiotics Use in the Pediatric Population
May, M. E., & So, T.-Y. (2014) · Clinical Pediatrics · doi:10.1177/0009922813518427 · Cited by 4
“In patients with IBS, treatment with probiotics, specifically LGG, has exhibited a decrease in the frequency of pain associated with IBS and the perception of pain intensity from the IBS symptoms.(8,9) The use of probiotics should be discussed with patients as a possible option”
BackgroundMicrobial Neuro-Immune Interactions and the Pathophysiology of IBD
Aguilera, M., & Melgar, S. (2016) · InTech eBooks · doi:10.5772/64832 · Cited by 7
“[70] Rousseaux C, Thuru X, Gelot A, Barnich N, Neut C, Dubuquoy L, et al.”
BackgroundIrritable bowel syndrome and the gut microbiota
Heenan, P. E., Keenan, J. I., Bayer, S. B., Simon, M., & Gearry, R. B. (2019) · Journal of the Royal Society of New Zealand · doi:10.1080/03036758.2019.1695635 · Cited by 4
Shalaginova, I. G., Matskova, L. V., Gunitseva, N. M., & Vakoliuk, I. A. (2019) · Ecological genetics · doi:10.17816/ecogen17491-102 · Cited by 5
“This is a substitution of pathogenic microorganisms during the following processes: the struggle for food sources, the interactions with metabolites, the production of bacteriocins, the inhibition of bacterial translocation, the strengthening of the GIT mucosa [78, 79], the effect on calcium-dependent potassium channe…”
BackgroundJiang, H., Li, R., Zhang, F., Zhou, F., Lin, J., Kong, N., Chen, H., Guo, L., Ye, C., Li, F., et al. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/4463063 · Cited by 5
Kashtanova, D. A., Tkacheva, O. N., & Boytsov, S. A. (2016) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2016-1-69-72 · Cited by 5
“Существуют и другие, малоизученные продукты лактобактерий, которым присваивают морфиноподобные и другие свойства [12].”
Possibilities of therapeutic manipulation of the gut microbiota
Drastich, P., Bajer, L., & Kverka, M. (2018) · Vnitřní lékařství · doi:10.36290/vnl.2018.091 · Cited by 4
“Lactobacillus acidophilus) s epitelovými buňkami indukuje expresi opioidních a ka nabinoidních receptorů u buněk střevní sliznice, a při spívá tak k modulaci vnímání viscerální bolesti [60].”
Enteric Neuromodulation for the Gut and Beyond
Patel, Y., & Pasricha, P. J. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034355 · Cited by 4
Sensory, antioxidant and rheological properties of different types of chocolates with probiotics
Laličić-Petronijević, J. (2012) · doi:10.2298/bg20121004lalicicpetronijevic · Cited by 4
de Almeida, M. M., Calviño, C., Reis-Gomes, C. F., Lombardi, I., Brand, A. L. M., Pazos-Moura, C. C., Garrett, R., Alves, M. A., & Trevenzoli, I. H. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109802 · Cited by 5
Immune dysregulation and gut microbiota: Connection to health and disease development
Boleti, A. P. D. A., Cardoso, P. H. D. O., Frihling, B. E. F., de Moraes, L. F. R. N., Nunes, E. A. C., Mukoyama, L. T. H., Biembengute, M. E. F., Melo, V. F., Morales, M., de Castro, A. P., et al. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00244 · Cited by 4
“L. acidophilus has been shown to influence the expression of cannabinoid receptors in the intestines of rodents (Rousseaux et al., 2007), while Akkermansia muciniphila increases endocannabinoid levels (Everard et al., 2013).”
Campanale, A., Mir, H.-D., Dumais, E., Inserra, A., Flamand, N., Chakravarty, M. M., Gantois, I., Siddiqui, N., Sonenberg, N., Gobbi, G., et al. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111575 · Cited by 3
Metadata
- Authors
- Rousseaux, C., Thuru, X., Gelot, A., Barnich, N., Neut, C., Dubuquoy, L., Dubuquoy, C., Merour, E., Geboes, K., Chamaillard, M., Ouwehand, A., Leyer, G., Carcano, D., Colombel, J.-F., Ardid, D., & Desreumaux, P.
- Affiliations
- Inserm (FR)
- Université Clermont Auvergne (FR)
- KU Leuven (BE)
- Corresponding author
- Desreumaux, Pierre
- ORCID
- Venue
- Nature Medicine
- Published
- 2006-12-10
- Volume
- 13
- Issue
- 1
- Pages
- 35-37
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1966470298
- Cited by
- 793
- References
- 16
- Citations by year
- 2026: 15 · 2025: 28 · 2024: 38 · 2023: 46 · 2022: 44 · 2021: 48 · 2020: 42 · 2019: 50 · 2018: 53 · 2017: 40 · 2016: 42 · 2015: 34 · 2014: 47 · 2013: 58 · 2012: 44
- FWCI
- 26.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- Lactobacillus acidophilus, intestinal pain, abdominal pain, irritable bowel syndrome, visceral hypersensitivity, mu-opioid receptor, cannabinoid receptors, intestinal epithelial cells, gut microbiota, analgesia, probiotics
- MeSH terms
- Administration, Oral, Analgesics, Opioid, Animals, Colon, Dose-Response Relationship, Drug, Humans, Indoles, Intestines, Lactobacillus acidophilus, Male, Mice, Inbred BALB C, Morphine, Naloxone, Narcotic Antagonists, Receptors, Opioid, Rectum, Abdominal Pain, Rats, Sprague-Dawley, Receptors, Opioid, mu, HT29 Cells, Probiotics, Receptors, Cannabinoid, Receptor, Cannabinoid, CB2, Mice, Rats, Cannabinoid Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.